BridgeMD
New treatment option for Breast Cancer
Official title Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
ClinicalTrials.gov ID: NCT07418125
What this study is testing
- What it's testing
- CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Patients with inflammatory breast cancer, regardless of cancer subtype (stage IIID)
- Patients with non-inflammatory breast cancer: triple-negative and HER2+ subtypes, from stage IIB to IIIA-C
- Adequate health status for neoadjuvant systemic treatment
You likely can't join if
- Inflammatory breast cancer stage IV
- Luminal A, luminal B subtypes of non-inflammatory breast cancer
- Stages I-IIA breast cancer
- Inability to understand or communicate in Slovenian
- Inability to follow protocol instructions
- Inappropriate health status for chemotherapy treatment
See the full eligibility criteria
- Patients with inflammatory breast cancer, regardless of cancer subtype (stage IIID)
- Patients with non-inflammatory breast cancer: triple-negative and HER2+ subtypes, from stage IIB to IIIA-C
- Adequate health status for neoadjuvant systemic treatment
- Inflammatory breast cancer stage IV
- Luminal A, luminal B subtypes of non-inflammatory breast cancer
- Stages I-IIA breast cancer
- Inability to understand or communicate in Slovenian
- Inability to follow protocol instructions
- Inappropriate health status for chemotherapy treatment
- Primary treatment with surgery
The study team makes the final eligibility decision.
Where it's taking place
- Ljubljana, Slovenia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ljubljana, Slovenia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.